Background illustration for clinical trials search

High Blood Pressure Clinical Trials

Browse 1,131 High Blood Pressure clinical trials enrolling across the United States and Canada. 85 people applied to High Blood Pressure studies last month. Search by city or state to find one near you.

Filter
1
Active & Responsive

Repeated CBD Administration and Cannabis Outcomes

for
Cannabis, Abuse Liability,
Location: Lexington KY
Sponsor: Hannah Harris

Sex: All

Age: 18 - 55

Code: NCT07434895

Early Phase 1, Recruiting
Active & Responsive

Effects of Eggshell Membrane and Curcumin Extract Supplementation, Separately or Combined, on Recovery From Intense Exercise

for
Exercise-induced Muscle Soreness, Exercise-induced Joint Pain,
Location: College Station TX
Sponsor: ESM Technologies, LLC

Sex: Male

Age: 18 - 40

Code: NCT07766720

Recruiting
Active & Responsive

Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)

for
Heart Failure, Heart Failure - NYHA II - IV
Location: Charleston SC, Minneota MN, Dallas TX
Sponsor: Echosens

Sex: All

Age: 18+

Code: NCT07222813

Recruiting
Active & Responsive

Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony

for
Blood Loss, Surgical, Blood Loss, Postoperative, Uterine Atony
Location: Ann Arbor MI
Sponsor: University of Michigan

Sex: Female

Age: 18+

Code: NCT07217899

Phase 2, Recruiting
Active & Responsive

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

for
Ovarian Cancer, Fallopian Tube Cancer
Location: Boston MA, New York NY, Philadelphia PA, Durham NC,
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT05287451

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Reset Challenge: Reducing High-risk Drinking for Cancer Prevention

for
Alcohol Drinking, Heavy Drinking, Binge Drinking
Location: Tulsa OK
Sponsor: University of Oklahoma

Sex: All

Age: 18 - 70+

Code: NCT07591428

Recruiting
Active & Responsive

Sleep and Circadian Interventions for College Students at High Risk of Suicide

for
Sleep Disturbance, Sleep, Depression, Suicide
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: All

Age: 18 - 25

Code: NCT07346014

Recruiting
Active & Responsive

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

for
Coronavirus Disease (COVID-19)
Location: The Bronx NY, New York NY, Teaneck NJ, Newark NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06667700

Phase 3, Recruiting
Active & Responsive

Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)

for
Tachycardia, Ventricular
Location: Boston MA, Hartford CT, New Haven CT, Philadelphia PA,
Sponsor: Varian, a Siemens Healthineers Company

Sex: All

Age: 18+

Code: NCT05765175

Recruiting
Active & Responsive

Phase II Randomized, Placebo- Controlled Study of Intralesional Nivolumab for High-risk Oral Premalignant Lesions

for
Premalignant Lesion
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06561087

Phase 2, Recruiting
Active & Responsive

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

for
Neuroblastoma, Sarcoma
Location: The Bronx NY, Washington D.C. DC, Columbus OH,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 1 - 40

Code: NCT05135975

Phase 2, Recruiting
Active & Responsive

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

for
Breast Neoplasms, Breast Cancer
Location: Norfolk VA, Nashville TN, Skokie IL, Houston TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06797635

Phase 2, Recruiting
Active & Responsive

Preventing Suicidal Behavior With Diverse High-Risk Youth in Acute Care Settings

for
Suicide, Attempted, Suicide Ideation, Suicide,
Location: New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Johns Hopkins University

Sex: All

Age: 12 - 24

Code: NCT06151158

Recruiting
Active & Responsive

Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors

for
Solid Tumor
Location: Pittsburgh PA, Atlanta GA, St Louis MO, Houston TX
Sponsor: Emory University

Sex: All

Age: 1 - 30

Code: NCT04469530

Phase 2, Recruiting
Active & Responsive

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

for
Breast Atypical Hyperplasia, Breast Carcinoma,
Location: Columbus OH, Chicago IL, Kansas City KS, Duarte CA
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 35+

Code: NCT05941520

Phase 2, Recruiting
Active & Responsive

Accelerated Intermittent Theta Burst Stimulation for Adolescent and Young Adult Depression With Elevated Suicide Risk

for
Major Depressive Disorder (MDD), Suicidal Ideation
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 15 - 25

Code: NCT07025720

Recruiting
Active & Responsive

Prehabilitation in High-risk Oncologic Surgery

for
Pancreatic Cancer, Colo-rectal Cancer, Gastric Cancer,
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center

Sex: All

Age: 18+

Code: NCT07638410

Recruiting
Active & Responsive

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

for
Acute Leukemia, Myelodysplastic Syndrome
Location: Palo Alto CA
Sponsor: Laguna Biotherapeutics, Inc.

Sex: All

Age: 1 - 39

Code: NCT07573111

Phase 1, Recruiting
Active & Responsive

Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis

for
JAK2 Mutation
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18+

Code: NCT07249840

Phase 1, Recruiting
Active & Responsive

A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis

for
Secondary AML, Myelofibrosis
Location: San Diego CA, Duarte CA, Sacramento CA
Sponsor: Aspera Biomedicines, Inc.

Sex: All

Age: 18+

Code: NCT07250646

Phase 1, Recruiting

What is high blood pressure?

Blood pressure is the force of blood against artery walls, written as two numbers: systolic, when the heart beats, over diastolic, when it rests. Under US guidelines, high blood pressure, or hypertension, is a reading consistently at or above 130 over 80. Over years, that extra force stiffens arteries and strains the heart, and it is the leading risk factor for stroke and a major cause of heart failure, heart attack, and kidney disease. Most of the time it has no symptoms, which is why it is called a silent condition and why it is found by measurement rather than by how you feel. Headaches, dizziness, or nosebleeds are usually not caused by ordinary high blood pressure, though very severe readings can cause them.

Treatment starts with lifestyle changes, and for about 4 in 5 adults with hypertension guidelines also recommend medicine, usually from several well established classes. The problem is not a lack of drugs but staying on them: daily pills are easy to miss, and control rates have stagnated. Research is answering that in three ways. Long acting medicines such as zilebesiran, which silences the liver's production of a blood pressure hormone with an injection every six months, are in Phase 3 outcome trials measuring heart attacks and strokes. A new class of pills that blocks aldosterone production, including baxdrostat, is in Phase 3, and one drug for hard to treat hypertension, aprocitentan, was approved in 2024. Device procedures that quiet the nerves to the kidneys have been approved since 2023 and are being refined. For the small group whose pressure stays high on three or more medicines, see our resistant hypertension page.

Types of high blood pressure clinical trials

Who can participate in high blood pressure clinical trials?

What is the newest treatment for high blood pressure?

Blood pressure categories, and why they matter for trials

Do high blood pressure trial participants get paid?

How to enroll in a high blood pressure clinical trial